Zentek Ltd Stock Price, News & Analysis

Zentek Ltd. (NASDAQ:ZTEK) announced a non-binding letter of intent with 1329307 BC Ltd. on February 13, 2023, to transfer its Albany Graphite Deposit to a new entity, SpinCo, which will be listed on a Canadian stock exchange. Management believes this move will help the project progress towards a prefeasibility study and unlock the asset's value, currently underappreciated in Zentek's share price. The transaction’s final structure will depend on consultations with advisors and requires various approvals. Zentek currently owns 100% of the deposit and aims for the separate entity to advance the project independent of its core operations.

Zentek Ltd. (NASDAQ:ZTEK, TSXV:ZEN) announced the development of ZenARMOR™, a novel corrosion protection technology utilizing functionalized Graphene Oxide. This innovative solution offers improved performance, self-healing properties, and potential environmental benefits due to its low active ingredient content. Third-party testing confirmed excellent corrosion resistance after 1,500 hours in ASTM B-117 tests. Zentek is pre-qualified for the Innovative Solutions Canada testing stream, having filed for a provisional patent and trademark for ZenARMOR™. The company aims to address the significant economic costs of corrosion, estimated at US$452 billion annually in the US.

Zentek Ltd. (Nasdaq:ZTEK), an intellectual property development company, announced the results of Phase 2 testing for its ZenGUARD™ technology in HVAC filtration. The ZenGUARD™ treated MERV 8 filters achieved a 34.56% filtration efficiency against the Phi6 virus, significantly improving from 7.24% in untreated filters. This advancement positions ZenGUARD™ as a potential game-changer for enhancing indoor air quality without incurring high costs for filter upgrades. Zentek is progressing towards commercialization, collaborating with federal organizations and seeking regulatory approvals in North America.

Zentek Ltd. (NASDAQ:ZTEK) has entered a Distribution Agreement with Southmedic Inc. for the distribution of its patented ZenGUARD™ surgical masks in Canada. Southmedic, a leading medical device distributor, aims to introduce ZenGUARD™ masks to hospitals, clinics, and long-term care facilities. This partnership is expected to secure stable demand in the surgical mask market, leveraging Southmedic's established network. Zentek’s ZenGUARD™ technology boasts 99% antimicrobial activity and enhanced filtration efficiency, reinforcing its value proposition in healthcare.

Zentek Ltd. (Nasdaq:ZTEK) announced the appointment of Mitch Swergold as the new Director of Investor Relations. Swergold brings extensive experience in technology investment as a former Senior Analyst and Portfolio Manager. His role will involve enhancing communication with investors and presenting updated business information. Concurrently, Zentek granted him 50,000 stock options at an exercise price of $1.93. The company's innovative products, particularly the antimicrobial ZenGUARD coating, continue to drive its mission in the healthcare sector.

Zentek Ltd. (NASDAQ:ZTEK) announced successful results from Phase 2 HVAC filter testing conducted by the National Research Council of Canada. The ZenGUARD™ coating applied to standard HVAC filters significantly reduced airborne contaminants without affecting airflow rates or energy consumption. This breakthrough could enhance air quality across various sectors, from healthcare to real estate. Zentek plans to further optimize filter configurations and finalize regulatory submissions, moving closer to commercializing ZenGUARD™ products.

Zentek Ltd. (NASDAQ:ZTEK) has been granted Patent Number 3,152,759 by the Canadian Intellectual Property Office for its ZenGUARD™ technology, which includes graphene-silver composites with antimicrobial uses. This patent, valid until September 20, 2041, supports applications in personal protective equipment (PPE) and HVAC systems. CEO Greg Fenton noted the significance of moving from concept to commercialization, emphasizing the importance of intellectual property and the technology's potential to enhance safety and environmental protection.

Zentek Ltd. (NASDAQ:ZTEK) has filed amended and restated audited financial statements for the year ending March 31, 2022. This update reflects necessary amendments requested by the Ontario Securities Commission due to changes in auditors. The amended financials now include the predecessor auditor's report for the comparative period. Zentek operates in the development of graphene and nanomaterials for healthcare, with its ZenGUARD™ coating demonstrating 99% antimicrobial activity, including against COVID-19.

Zentek Ltd. (NASDAQ:ZTEK) has announced a 4-year, $1.6M research project with the University of Toronto and Ford's Powertrain Engineering Research Development Centre to develop next-generation graphene-based battery materials. Funded in part by $1.2M from the Mitacs Accelerate program, the project aims to enhance energy density and charging rates for automotive batteries. Notably, Zentek has developed a patent-pending graphene-wrapped silicon anode material that demonstrates significant improvements in capacity and cycle stability, potentially revolutionizing electric vehicle battery technology.